Table 1.
Baseline characteristics of study patients (on ECMO day 1).
| Variable | Total population |
|---|---|
| # Patients | 41 |
| Age (Years) | 0.6 (0.0–17.2) |
| Gender | |
| Female | 14 (34.1%) |
| Male | 27 (65.9%) |
| # Ventricles | |
| Univentricular | 11 (26.8%) |
| Biventricular | 30 (72.3%) |
| Diagnostic Category | |
| Heart Failure | 15 (36.6%) |
| Congenital Heart Disease | 23 (56.1%) |
| Other | 3 (7.3%) |
| Height (cm) | 70.0 (40.5–180.0) |
| Weight (kg) | 8.5 (1.5–80.0) |
| Creatinine | 0.8 (0.2–2.0) |
| Bilirubin | 1.9 (0.3–12.0) |
| ALT | 52.5 (4.0–3521) |
| AST | 131 (13.0–4200) |
| Lactate | 5.7 (1.5–19.0) |
| Platelet count | 70.0 (8.0–267) |
| PT | 23.0 (8.6–88.3) |
| MOFI | 3.0 (2.0–5.0) |
| SvO2 | 70.0 (20.0–94.0) |
Continuous variables presented as median (range). Categorical variables presented as n (%).
ALT, alanine transaminase; AST, aspartate transaminase; PT, prothrombin time; MOFI, modified organ failure index; SvO2, mixed venous oxygen saturation; ECMO, extracorporeal membrane oxygenation.